SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co.
MTC 2.305+9.2%Nov 21 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TheSlowLane who wrote (518)11/11/1998 8:43:00 PM
From: Anthony Wong  Read Replies (1) of 2539
 
Paul and Dan, from the Dow Jones article at Post 517:

Monsanto's plan to finance the acquisitions received generally positive reactions from analysts.

The moves Monsanto announced will enable it to keep a lid on debt.

Good move by MTC management! Some weeks ago when the AHP/MTC deal fell through, Wall Street reaction was generally negative, as there were grave concerns as to how they are going to fund their recent acquisitions. With the financing issue now taken care off, perhaps investors can now focus on Celebrex's revenue potential (of course we'll still need to get FDA approval!).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News